# A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.

> **NCT05203601** · PHASE1 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 36 (actual)

## Conditions studied

- Tumor

## Interventions

- **BIOLOGICAL:** SIBP-03

## Key facts

- **NCT ID:** NCT05203601
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-26
- **Primary completion:** 2022-12-06
- **Final completion:** 2022-12-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203601, "A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05203601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*